CA2501751C - Therapie combinee des infections au vih
- Google Patents
Therapie combinee des infections au vih
Download PDF
Info
Publication number
CA2501751C
CA2501751CCA2501751ACA2501751ACA2501751CCA 2501751 CCA2501751 CCA 2501751CCA 2501751 ACA2501751 ACA 2501751ACA 2501751 ACA2501751 ACA 2501751ACA 2501751 CCA2501751 CCA 2501751C
Authority
CA
Canada
Prior art keywords
product
grams
hiv
aids
micron filter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OHR Pharmaceutical Inc
Original Assignee
OHR Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OHR Pharmaceutical IncfiledCriticalOHR Pharmaceutical Inc
Priority claimed from CA002285463Aexternal-prioritypatent/CA2285463C/fr
Publication of CA2501751A1publicationCriticalpatent/CA2501751A1/fr
Application grantedgrantedCritical
Publication of CA2501751CpublicationCriticalpatent/CA2501751C/fr
Стимулятор секреции глюкагон-подобного пептида 1, продукты питания или напитки, стимулирующие секрецию глюкагон-подобного пептида 1, ингибитор постпрандиальной гипергликемии и продукты питания или напитки, ингибирующие постпрандиальную гипергликемию
Traitement combine des infections a vih mettant en oeuvre la thymosine, l'interleukine et des inhibiteurs de replication du vih ou de transcriptase reverse